Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis

Rheumatology International

Volumn 17, Issue 2, 1997, Pages 67-73

  Nordstrom D ^a   Lindroth, Y ^b   Marsal, L ^c   Hafstrom I ^d   Henrich, C ^e   Rantapaa Dahlqvist S ^f   Engstrom Laurent A ^g   Fyhrquist, F ^h   Friman, C ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Slottstadens Läkargrupp   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

^e Central Hospital   (Sweden)

^f UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^g FALUN HOSPITAL   (Sweden)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Anemia of chronic disease; Erythropoietin; Inflammation; Iron supplementation; Rheumatoid arthritis

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SKIN DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANEMIA; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED;

EID: 0030758577     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960050011     Document Type: Article

References (41)

1. Cartwright GE, Lee GR (1971) The anemia of chronic disorders. Br J Haematol 21: 147-152
2. Hansen NE (1983) The anemia of chronic disorders: a bag of unsolved questions. Scand J Haematol 31: 397-402
3. Schilling RF (1991) Anemia of chronic disease: a misnomer. Ann Intern Med 115: 572-578
4. Ward HP, Gordon B, Pickett JC (1969) Serum levels of erythropoietin in rheumatoid arthritis. J Lab Clin Med 74: 93-97
5. Pavlovic-Kentera V, Ruvidic R, Milenkovic P, Marinkovic D (1979) Erythropoietin in patients with rheumatoid arthritis. Scand J Haematol 23: 141-145
6. Birgegard G, Hallgren R, Caro J (1987) Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anemia and the effect of anti-inflammatory treatment. Br J Haematol 65: 479-483
7. Baer An, Dessypris EN, Goldwasser E, Krantz SB (1987) Blunted erythropoietin response in anemia in rheumatoid arthritis. Br J Haematol 66: 559-564
8. Vreugdenhil G, Swaak AJG (1990) Anemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment. Rheumatol Int 9: 243-257
9. Erslev AJ, Caro J, Miller O, Silver R (1980) Plasma erythropoietin in health and disease. Ann Lab Clin Sci 10: 250-257
10. Roodman GD, Bird A, Hutzler D, Montgomery W (1987) Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL-60, and HEL cells. Exp Hematol 15: 928-935
11. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, et al (1988) Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 167: 1211-1227
12. Teppo A-M, Maury CPJ (1987) Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 33: 2024-2027
13. Maury CPJ, Andersson LC, Teppo A-M, Partanen S, Juvonen E (1988) Mechanism of the anemia in rheumatoid arthritis: demonstration of raised interleukin 1β concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukemia (HEL) cells in vitro. Ann Rheum Dis 47: 972-978
14. Platanias LC, Vogelzang NJ (1990) Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med 89: 621-629
15. Johnson RA, Waddelow TA, Caro J, Oliff A, Roodman GD (1989) Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 74: 130-137
16. Akahane K, Hosoi T, Urabe A, Kawakami M, Takaku F (1987) Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells. Int J Cell Cloning 5:16-26
17. Broxmayer HE, Lu L, Plazer E, Feit C, Juliano L, Rubin BY (1983) Comparative analysis of the influences of human gamma, alpha, and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulosyte-macrophage (CFU-GM) progenitor cells. J Immunol 131: 1300-1305
18. Means RT, Dessypris EN, Krantz SB (1992) Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 150: 59-64
19. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, et al (1990) In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 75: 1602-1605
20. Metsärinne K, Nordström D, Konttinen YT, Teppo A-M, Fyhrquist F (1992) Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 12: 93-96
21. Wilder RL, Lafyatis R, Robets AB, Case JP, Kumkumian GK, Sano H, et al (1990) Transforming growth factor-β in rheumatoid arthritis. Ann NY Acad Sci 593: 197-207
22. Faquin WC, Schneider TJ, Goldberg MA (1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79: 1987-1994
23. Jelkman W, Pagel H, Wolff M, Fandrey J (1991) Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 50: 301-308
24. Konijn AM, Hershko C (1977) Ferritin synthesis and inflammation. I. Pathogenesis of impaired iron release. Br J Haematol 37: 7-16
25. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH (1989) Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 61: 319-322
26. Rogers J, Durmowics G, Kasschau K, Lacroix L, Bridges K (1991) A motif with the 5′non-coding regions of acute phase mRNAs mediates ferritin translation by IL-1β and may contribute to the anemia of chronic disease. Blood 367 a [Suppl 1]
27. Means RT, Olsen NJ, Krantz SB, Desspris EN, Graber SE. Stone WJ, et al (1989) Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin. Clinical and in vitro studies. Arthritis Rheum 32: 638-642
28. Takashina N, Kondo H, Kashiwazaki S (1990) Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol 17: 885-886
29. Murphy EA, Bell AL, Wojtulewski J, Brzeski M, Madhok R, Cabell HA (1994) Study of erythropoietin in treatment of anemia in patients with rheumatoid arthritis. BMJ 309: 1337-1338
30. Pincus T, Olsen NJ, Russel IJ, Wolfe F, Harris ER, Schnitzer TJ, et al (1990) Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. J Rheumatol 17:885-886
31. Pettersson T, Rosenlöf K, Friman C, Mickos A, Fyhrquist F (1993) Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation. Scand J Rheumatol 22: 188-193
32. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324
33. Fries JF, Spitz PW, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23: 137-145
34. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E (1981) The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 15a: 221-229
35. Wiklund I, Romanus B, Hunt SM (1988) Self-assessed disability in patients with arthrosis of the hip. Reliability of the Swedish version of the Nottingham Health profile. Int Disabil Studies 10: 159-163
36. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35: 498-502
37. Egrie JC, Lane J, Gaines RE, Tam RC (1987) Development of radioimmunoassay for human erythropoietin as tracer and immunogen. J Immunol Methods 99: 235-241
38. Cazzola M, Ponchio L, Benedetti F de, Ravelli A, Rosti V, Beguin Y, et al (1996) Defective iron supply for erythropoiesis and adequate erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood 87: 4824-4830
39. Patterson C, Turpie ID, Benger AM (1985) Assessment of iron stores in anemic geriatric patients. J Am Geriatr Soc 33: 764-767
40. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316: 73-78
41. Goodnough LT (1989) Increased collection of autologous blood preoperatively by recombinant human erythropoietin therapy. N Engl J Med 321: 113-116